tiprankstipranks
Senti Biosciences (SNTI)
NASDAQ:SNTI
US Market
Holding SNTI?
Track your performance easily

Senti Biosciences (SNTI) Financial Statements

91 Followers

Senti Biosciences Financial Overview

Senti Biosciences's market cap is currently ―. The company's EPS TTM is $-15.597; its P/E ratio is -0.14; Senti Biosciences is scheduled to report earnings on March 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue---$ -250.00K$ 255.00K
Gross Profit---$ -333.00K$ 338.00K
EBIT$ -28.87M$ -11.20M$ -14.51M$ -9.41M$ -18.18M
EBITDA$ -27.40M$ -9.74M$ -13.05M$ -6.87M$ -16.37M
Net Income Common Stockholders$ -28.87M$ -11.20M$ -12.11M$ -18.72M$ -14.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.48M$ 15.86M$ 23.72M$ 35.93M$ 39.43M
Total Assets$ 57.72M$ 86.91M$ 102.19M$ 119.48M$ 131.77M
Total Debt$ 34.71M$ 35.74M$ 36.72M$ 37.67M$ 37.31M
Net Debt$ 24.23M$ 19.88M$ 13.00M$ 1.74M$ -2.12M
Total Liabilities$ 41.73M$ 42.77M$ 46.09M$ 52.57M$ 48.83M
Stockholders Equity$ 15.99M$ 44.15M$ 56.09M$ 66.91M$ 82.94M
Cash Flow-
Free Cash Flow$ -7.81M$ -8.35M$ -11.70M$ -7.04M$ -17.24M
Operating Cash Flow$ -7.87M$ -8.35M$ -11.68M$ -7.04M$ -15.38M
Investing Cash Flow$ 60.00K-$ -15.00K$ 101.00K$ 21.14M
Financing Cash Flow$ 2.44M--$ 556.00K$ -23.00K
Currency in USD

Senti Biosciences Earnings and Revenue History

Senti Biosciences Debt to Assets

Senti Biosciences Cash Flow

Senti Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis